Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 3:50 pm Unchanged |
2020-12-31 | 13G | SUNESIS PHARMACEUTICALS INC CO SNSS |
CAXTON CORP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-02-16 3:30 pm Purchase |
2021-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
CAXTON CORP | 3,098,447 8.800% |
1,140,204 (+58.23%) |
Filing History |
| 2020-10-14 1:52 pm Purchase |
2020-10-08 | 13G | Rezolute, Inc. RZLT |
CAXTON CORP | 564,243 6.600% |
564,243 (New Position) |
Filing History |
| 2020-10-01 5:55 pm Purchase |
2020-02-13 | 13G | CTI BioPharma Corp. CTIC |
CAXTON CORP | 4,487,317 6.100% |
4,487,317 (New Position) |
Filing History |
| 2020-09-23 10:37 am Purchase |
2020-09-17 | 13D | Strongbridge Biopharma plc SBBP |
CAXTON CORP | 10,280,682 15.200% |
1,765,853 (+20.74%) |
Filing History |
| 2020-06-22 4:52 pm Purchase |
2020-06-15 | 13G | Cardiff Oncology, Inc. CRDF |
CAXTON CORP | 1,958,243 9.900% |
1,958,243 (New Position) |
Filing History |